Silexion Therapeutics Corp (NasdaqCM: SLXN)
Health Care · Biotechnology · IL
$0.15
-28.70% today · -99.6% 1Y
Silexion Therapeutics Corp (NasdaqCM: SLXN) operates in the Biotechnology industry within the Health Care sector. The company is valued at $850.72K and employs 14 people.
Over the last twelve months the share price has lost 99.6%, trading between 0.15 and 36.50.
Tweenvest scores Silexion Therapeutics Corp across four factors: quality 34/100, value 32/100. Its strongest factor is quality.
SLXN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $850.72K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -38.75
- Dividend yield
- —
- Beta (5Y)
- -0.30
- 52-week high
- $36.50
- 52-week low
- $0.15
- Avg volume (3M)
- —
- Shares outstanding
- 5.56M
- Employees
- 14
- Next earnings
- —
About Silexion Therapeutics Corp
Silexion Therapeutics LTD is a biopharmaceutical company specializing in the discovery and advancement of RNA interference (RNAi)-based cancer therapies and their associated delivery systems, with a focus on treating aggressive solid tumors. The company's strategy for addressing these tumors relies on its proprietary LODER delivery platform. Its product pipeline features several key candidates: SiG12D-LODER, which has progressed through both preclinical studies and an open-label Phase I clinical trial for pancreatic cancer; Prostate-LODER, currently undergoing preclinical evaluation for prostate cancer; and GBM-LODER, also in preclinical development, targeting Glioblastoma Multiforme, a highly malignant primary brain tumor. Founded in 2008, Silexion Therapeutics is headquartered in Jerusalem, Israel.
- ISIN
- KYG1281K1489
- Founded
- 2008
- Listed since
- Aug 16, 2024
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| BioXcel Therapeutics, Inc.OTCPK: BTAI.Q | $904.73K | $0.03 | -29.51% |
| Yubo International Biotech LimitedOTCPK: YBGJ | $886.19K | $— | — |
| Sunshine Biopharma, Inc.NasdaqCM: SBFM | $859.99K | $0.22 | -34.34% |
| Epigenomics AGDB: ECX | $858.33K | €0.87 | -1.14% |
| Alligator Bioscience AB (publ)OM: ATORX | $837.19K | Skr0.01 | -13.73% |
| Agentix Corp.OTCPK: AGTX | $801.34K | $0.02 | — |
| Hindustan Bio Sciences LimitedBSE: 532041 | $766.86K | Rs7.10 | -4.70% |
| Decoy Therapeutics Inc.NasdaqCM: DCOY | $766.57K | $1.17 | -20.41% |
Figures last refreshed Oct 18, 2026.